We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $6.04 | — | — | $1.61B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $3.66 | — | — | $1.22B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $12.34 | — | — | $3.8B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $8.87 | — | — | $2.35B | Reported |
Consensus PT $173.44 · 16 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 27. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 05. 22. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
Compare a firm's past rating changes and its actions on other stocks in the same sector.